Treace Medical Concepts, Inc. (TMCI)

Market Closed

1 Sep, 20:00

NASDAQ (NGS)

4. 60

-0.1

-2.1277%

304.9M Market Cap

- P/E Ratio

- Div Yield

254,453 Volume

-0.93 Eps

$ 4.7

Previous Close

Investors:

Add Transaction

Day Range

4.55 4.69

Year Range

1.17 7.63

Want to track TMCI and more in your Portfolio? 🎯

Get Started For Free

Treace Medical Concepts, Inc. (TMCI) Q2 2026 Earnings Call Transcript

Seekingalpha | 3 weeks ago

Treace Medical Concepts Q2 Earnings Call Highlights

Treace Medical Concepts NASDAQ: TMCI reported second-quarter 2026 revenue of $45.4 million, down 4% from the prior-year period, as lower procedure-kit sales to stocking distributors and a continued shift toward lower-priced minimally invasive products weighed on reported sales.

Marketbeat | 3 weeks ago

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.3. This compares to a loss of $0.28 per share a year ago.

Zacks | 3 weeks ago

Treace Medical Concepts Q1 Earnings Call Highlights

Treace Medical Concepts NASDAQ: TMCI reaffirmed its full-year 2026 revenue outlook after reporting a first-quarter revenue decline, as management said new product adoption is helping drive procedure volume momentum despite pricing and mix headwinds.

Marketbeat | 3 months ago

Treace Medical Concepts, Inc. (TMCI) Q1 2026 Earnings Call Transcript

Seekingalpha | 3 months ago

Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates

Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.25 per share a year ago.

Zacks | 3 months ago

Treace Medical Concepts, Inc. (TMCI) Q4 2025 Earnings Call Transcript

Seekingalpha | 6 months ago

Treace Medical Concepts, Inc. (TMCI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seekingalpha | 7 months ago

Treace Medical Concepts, Inc. (TMCI) Q3 2025 Earnings Call Transcript

Treace Medical Concepts, Inc. ( TMCI ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Trip Taylor John Treace - Founder, Chairman & CEO Mark Hair - Chief Financial Officer Conference Call Participants Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Marie Thibault - BTIG, LLC, Research Division Jayna Renee Francis - UBS Investment Bank, Research Division Presentation Trip Taylor Good afternoon, everyone, and welcome to our third quarter 2025 earnings conference call. Participating from the company today will be John Treace, Chief Executive Officer; and Mark Hair, Chief Financial Officer.

Seekingalpha | 9 months ago